Mometasone Drug Implant

Brand(s)
Propel
Category(s)
other
SPL Type(s)
Medical Device
Master SPL
Intersect Ent, Inc. (2014-12-01)
Oldest Current Product
2011-08-19
License(s)
PREMARKET APPLICATION
RxNORM
DRUG IMPLANT\MOMETASONE
SPL Active
NASAL\IMPLANT\MOMETASONE FUROATE
SPL Moiety
NASAL\IMPLANT\MOMETASONE FUROATE

product(s) by strength(s)

mometasone furoate 0.37 mg drug implant

product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formspl
1105990000PropelPREMARKET APPLICATIONIntersect Ent, Inc.2011-08-19MOMETASONE FUROATENASALIMPLANT6befbf16-3f60-4ce8-94ec-5ce6a2b7f4e1
2105990001PropelPREMARKET APPLICATIONIntersect Ent, Inc.2012-09-21MOMETASONE FUROATENASALIMPLANT6befbf16-3f60-4ce8-94ec-5ce6a2b7f4e1

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
16befbf16-3f60-4ce8-94ec-5ce6a2b7f4e1 (view SPL)Propel/Propel Mini (mometasone furoate implant, 370 g)otherMedical DeviceIntersect Ent, Inc.MANUFACTURE2014-12-013105990000, 105990001

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII